Overview

A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

Status:
Withdrawn
Trial end date:
2019-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the effect of food on the single-dose PK of TAK-659 in participants with advanced solid tumors and/or lymphomas.
Phase:
Phase 1
Details
Lead Sponsor:
Millennium Pharmaceuticals, Inc.